- Home
- SYK
as 12-20-2024 4:00pm EST
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
| Founded: | 1941 | Country: | United States |
| Employees: | N/A | City: | PORTAGE |
| Market Cap: | 147.5B | IPO Year: | N/A |
| Target Price: | $408.21 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 19 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 9.33 | EPS Growth: | 38.37 |
| 52 Week Low/High: | $292.43 - $398.20 | Next Earning Date: | 01-28-2025 |
| Revenue: | $21,974,000,000 | Revenue Growth: | 10.51% |
| Revenue Growth (this year): | 11.29% | Revenue Growth (next year): | 8.14% |
Stock Insider Trading Activity of Stryker Corporation (SYK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Stiles Spencer S | SYK | Group President | Nov 14 '24 | Sell | $391.16 | 514 | $201,056.24 | 50,611 | |
| Lobo Kevin | SYK | Chair and CEO | Nov 7 '24 | Sell | $368.76 | 57,313 | $21,131,479.29 | 139,071 | |
| STRYKER RONDA E | SYK | Director10% Owner | Nov 5 '24 | Sell | $366.98 | 230,000 | $84,494,989.68 | 3,186,635 |
Latest Stryker Corporation News
SYK Breaking Stock News: Dive into SYK Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
TD Cowen Raises Price Target on Stryker to $435 From $400
TipRanks
3 days ago
Stryker price target raised to $409 from $380 at Truist
Morningstar Research
3 days ago
Analyst Report: Stryker Corporation
Zacks
4 days ago
HAE or SYK: Which Is the Better Value Stock Right Now?
MT Newswires
4 days ago
Baird Adjusts Stryker Price Target to $421 From $405, Maintains Outperform Rating
MT Newswires
4 days ago
Truist Securities Raises Price Target on Stryker to $409 From $380, Keeps Hold Rating
Zacks
5 days ago
Top Stock Reports for Tesla, Broadcom & Bank of America
Insider Monkey
5 days ago
Reasons to Invest in Stryker Corp. (SYK)
Compare SYK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SYK Stryker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.